Kate Campbell, PhD, is currently the Chief of Staff for the Cardiovascular, Renal and Metabolism Therapy Area Clinical Department at AstraZeneca and serves as the Director in Business Planning & Operations within BioPharmaceuticals R&D. Previously, Kate completed a PhD in Biochemistry at the University of Cambridge and has held research and leadership positions at AstraZeneca and Chalmers University of Technology. Passionate about optimizing team performance and fostering thoughtful leadership, Kate has led significant initiatives in business planning and data analysis.
This person is not in any teams
This person is not in any offices